Drug application
MYCOSTATIN (NYSTATIN)
Drugs@FDA NDA 050619 · DELCOR ASSET CORP
Key facts
| Drug name | MYCOSTATIN |
|---|---|
| Active ingredients | NYSTATIN |
| Application type | NDA |
| Application number | 050619 |
| Company | DELCOR ASSET CORP |
| Dosage forms | PASTILLE, ORAL |
| Strength | 200,000 UNITS |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Apr 9, 1987 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: